MedPage Today October 9, 2024
— Secondary analysis suggests lack of clinically meaningful differences in effectiveness
Mindfulness meditation appeared to be similar to escitalopram (Lexapro) in reducing anxiety symptoms at 8 weeks based on several patient- and clinician-reported measures, a secondary analysis of a randomized clinical trial showed.
Among 276 adults who underwent mindfulness-based stress reduction (MBSR) or received escitalopram, between-group differences corresponded to small effect sizes (Cohen d ≤0.20), suggesting a lack of clinically meaningful differences in effectiveness between treatments, wrote Elizabeth A. Hoge, MD, of Georgetown University Medical Center in Washington, D.C., and co-authors in a research letter in JAMA Network Open.
“The bottom line is the two treatments were very similar,” Hoge told MedPage Today. “That confirms our first finding, that meditation...
Today's Sponsors
Today's Sponsor